IMNM
Price
$9.40
Change
-$1.12 (-10.65%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
915.71M
70 days until earnings call
SYBX
Price
$1.50
Change
+$0.04 (+2.74%)
Updated
Sep 8, 04:29 PM (EDT)
Capitalization
17.08M
Interact to see
Advertisement

IMNM vs SYBX

Header iconIMNM vs SYBX Comparison
Open Charts IMNM vs SYBXBanner chart's image
Immunome
Price$9.40
Change-$1.12 (-10.65%)
Volume$26.53K
Capitalization915.71M
Synlogic
Price$1.50
Change+$0.04 (+2.74%)
Volume$182
Capitalization17.08M
IMNM vs SYBX Comparison Chart in %
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. SYBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a StrongBuy and SYBX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (IMNM: $10.52 vs. SYBX: $1.46)
Brand notoriety: IMNM and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 170% vs. SYBX: 17%
Market capitalization -- IMNM: $915.71M vs. SYBX: $17.08M
IMNM [@Biotechnology] is valued at $915.71M. SYBX’s [@Biotechnology] market capitalization is $17.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileSYBX’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • SYBX’s FA Score: 1 green, 4 red.
According to our system of comparison, SYBX is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 7 TA indicator(s) are bullish while SYBX’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 7 bullish, 2 bearish.
  • SYBX’s TA Score: 5 bullish, 1 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than SYBX.

Price Growth

IMNM (@Biotechnology) experienced а +10.62% price change this week, while SYBX (@Biotechnology) price change was +0.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.99%. For the same industry, the average monthly price growth was +10.86%, and the average quarterly price growth was +33.06%.

Reported Earning Dates

IMNM is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($916M) has a higher market cap than SYBX($17.1M). SYBX YTD gains are higher at: 4.286 vs. IMNM (-0.942). SYBX has higher annual earnings (EBITDA): -11.07M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. SYBX (17M). SYBX has less debt than IMNM: SYBX (0) vs IMNM (4.14M). IMNM has higher revenues than SYBX: IMNM (12.6M) vs SYBX (0).
IMNMSYBXIMNM / SYBX
Capitalization916M17.1M5,357%
EBITDA-187.92M-11.07M1,698%
Gain YTD-0.9424.286-22%
P/E RatioN/A6.36-
Revenue12.6M0-
Total Cash268M17M1,576%
Total Debt4.14M0-
FUNDAMENTALS RATINGS
SYBX: Fundamental Ratings
SYBX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
24
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMSYBX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 18 days ago
82%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 21 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KALV15.820.62
+4.08%
KalVista Pharmaceuticals
ACGL91.29-0.93
-1.01%
Arch Capital Group Ltd
NPWR2.20-0.03
-1.35%
NET Power
ARTW3.21-0.09
-2.73%
Art's-Way Manufacturing Co
VEON55.01-2.84
-4.91%
VEON Ltd

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+7.35%
IDYA - IMNM
59%
Loosely correlated
+5.15%
DNTH - IMNM
55%
Loosely correlated
+7.46%
SYRE - IMNM
54%
Loosely correlated
+0.06%
RXRX - IMNM
53%
Loosely correlated
+1.99%
IPSC - IMNM
53%
Loosely correlated
+5.41%
More

SYBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with SBHMY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then SBHMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
N/A
SBHMY - SYBX
39%
Loosely correlated
N/A
BTAI - SYBX
37%
Loosely correlated
+6.16%
SPHRF - SYBX
29%
Poorly correlated
N/A
ALT - SYBX
28%
Poorly correlated
+6.18%
IMNM - SYBX
28%
Poorly correlated
+7.35%
More